Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial

Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The new screenshot shows the same study record with only minor UI/layout changes and updated dates; there are no changes to study results, eligibility criteria, enrollment numbers, or key study details.
    Difference
    0.5%
    Check dated 2025-10-29T10:13:05.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    - Added a government funding notice and operating status information, and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    5%
    Check dated 2025-10-07T23:17:22.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Core content related to Sickle cell anemia was removed; a new version tag v3.1.0 was added to the page while the previous version tag v3.0.2 was removed.
    Difference
    0.7%
    Check dated 2025-09-30T02:39:23.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.3%
    Check dated 2025-09-15T19:26:12.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-08T15:07:28.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while also removing several location-related terms and references to safety and sickle cell anemia.
    Difference
    3%
    Check dated 2025-09-01T09:43:39.000Z thumbnail image

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.